INTEGRATED BIOPHARMA INC Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD from Q3 2016 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from Q3 2016 to Q3 2024.
- Integrated Biopharma Inc Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending September 30, 2024 was $12K, a 20% increase year-over-year.
- Integrated Biopharma Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $42K, a 2.44% increase from 2023.
- Integrated Biopharma Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $41K, a 63.7% decline from 2022.
- Integrated Biopharma Inc annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $113K, a 43.8% decline from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Growth (%)